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Background: Fast-track recovery protocols are applied to major surgeries, including hepatectomies. The
optimal duration of thoracic epidural catheter has not yet been deﬁned.
Objective: To determine the ideal time to remove the epidural catheter after major hepatectomy.
Patientsemethods: Forty-eight consecutive patients who underwent major hepatectomy over 4 years
were studied. The data from laparoscopic hepatectomy were not included. Patients who underwent
hepaticojejunostomy were included. A modiﬁed protocol of rapid postoperative recovery was imple-
mented. In the ﬁrst 24 patients, an epidural catheter was maintained for 4 days (group A), while in the
next 24, the catheter was maintained for 2 days (group B). The length of hospital stay, time of functional
recovery, and use of opioids and laxatives were recorded.
Results: There was no postoperative mortality. The average length of hospital stay was 6.92  1.79 and
6.09  2.08 days for groups A and B, respectively. The mean functional recovery was 5.46  0.3 and
5.26  0.91 days for groups A and B, respectively. However, in group B, more opioid analgesics by 50% and
more laxatives by 17% were used.
Conclusions: After major hepatectomy, a reduction from 4 to 2 days’ duration of the epidural catheter
may lead to a reduction in the length of hospital stay.
 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Fast track (FT) or enhanced recovery after surgery (ERAS) pro-
grams are often applied tomajor surgeries, including hepatectomy.1
It is well established that improper pain management, enteric
dysfunction and immobilization of the patient increases the dura-
tion of the hospital stay after colorectal surgery.2 Hepatic resections
and elective colorectal surgeries are procedures that involve high
stress, and convalescence may sometimes be slow.
Despite recent developments in the perioperative and post-
operative care of these patients, the optimal duration of the
thoracic epidural catheter is not yet deﬁned. Many FT protocols
have been introduced over the years with many variations in the
management of postoperative epidural analgesia.3,4
According to our center’s FToriginal protocol, a thoracic epidural
catheter was utilized for 4 days, and the use of a urinary bladder: þ30 2310895196.
ciates Ltd. Published by Elsevier Ltcatheter 4 days followed. The aim of this study was to deﬁne
whether the reduction from 4 to 2 days of using an epidural cath-
eter led to a reduction in the length of hospital stay after a major
hepatectomy.
2. Materials and methods
This study is a retrospective analysis of the prospectively recorded data of 48
consecutive patients who underwent operations from June 2008 to June 2012. In the
ﬁrst 24 patients, the epidural catheter was maintained for 4 days (control group),
while in the next 24 patients, it was maintained for 2 days only (study group). The
data from patients who underwent laparoscopic hepatectomy were not included,
while the data from patients with hepatectomy and hepatojejunostomy were
included.
The preoperative evaluation and preparation for anesthesia and surgery con-
sisted of standard plasma liver function tests, preoperative radiological evaluations
with triple phase contrast-enhanced computed tomography (CT) and/or selective
magnetic resonance imaging (MRI), with or without CT-positron emission tomog-
raphy (CT-PET). Decisions on the patients’ treatment strategies were multidisci-
plinary. Patients’ demographics, ASA grades, diagnoses, preoperative chemotherapy
regimens, operative procedures, blood loss, complications, duration of hospital stay
and total length of stay with readmission were recorded. The Brisbane terminology
was used for the description of the resections.5 The FT protocol in our centerd. All rights reserved.
Table 1
Patient demographics and diagnoses.
Groups A (n ¼ 24) B (n ¼ 24) p-Value
Age (range) 48.8 (31e75) 57.8 (32e73) n/s





Pre-op chemotherapy 8 13
Diagnosis
Colorectal mets 8 12
Neuroendocrine mets 2 3
Cholangiocarcinoma 7 3
HCC 2 3
Benign tumors 5 3
*n/s denotes absence of statistical signiﬁcance (p > 0.05).
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unless the hepatectomy is non-anatomical,6 3) immediate extubation, 4) unre-
stricted diet from the ﬁrst postoperative day, 5) mobilization as much as possible
from the ﬁrst postoperative day, 6) systematic administration of 4 g of paracetamol,
7) systematic administration of 2 g of magnesium, 8) maintaining central vein
pressure < 5 cm H2O during hepatectomy and the ﬁrst 48 h7 and 9) glucose
clamping.8 The number of deaths, number of postoperative complications/read-
missions, time of functional recovery, time of hospital stay, number of readmissions,
use of opioids analgesics and use of laxatives were studied too.
Functional recovery was achieved when patients fulﬁlled the following criteria:
tolerance of oral diet, full mobilization (as prior to surgery), pain control with only
oral analgesics (not opioids), passage of ﬂatus and normalization of liver biochemical
tests. When all ﬁve criteria were met, the patient was discharged.
Any complication occurred within 90 days of surgery was considered post-
operative. Major complications, as deﬁned by the International Study Group of Liver
Surgery (ISGLS), included the following: 1) hepatic failure,9 2) bile leakage10 and 3)
hemorrhage.11 The Dindo and Clavien classiﬁcation was used for the determination
of the severity of complications.12
2.1. Surgical technique
A typical bilateral subcostal “chevron” incision with possible midline extension
(“Mercedes-Benz” incision) was performed. A routine intraoperative ultrasonogra-
phy was performed at the beginning of the operation to conﬁrm the number and
size of the lesions in relation to the vascular structures of the liver. The inﬂow
maneuver (Pringle’s technique) was not used.
Once the hepatic capsule was marked, the ﬁrst 2 cm of the parenchyma tran-
section was performed using ultrasonic vibration (Harmonic Focus Long Curved
Shears, Ethicon, Norderstedt, Germany). Deeper transaction was performed by
pressurized jet of water (Hydro-Jet, Erbe, Tubingen, Germany) and stapler devices
(Echelon Flex Endopath Stapler, Ethicon, Norderstedt, Germany). Drains were placed
selectively, and the abdomen was closed according to the standard surgical fashion.
2.2. Anesthesia and postoperative management
All patients were managed with thoracic epidural anesthesia, with the catheter
inserted immediately before the beginning of the operation. After i.v. administration
of a bolus dose of 500 ml of colloids at 60 mg/ml (Venofudin, B. Braun, Melsungen,
Germany), the catheter were introduced at the T6-T7 (or T5-T6) intervertebral space.
A test dose of 3 ml ropivacaine 7.5 mg/ml (Naropeine, AstraZeneca, Athens, Greece)
was administered to exclude intrathecal end/or intravascular placement of the
catheter. After a negative test dose, a single dose bolus of 6 ml ropivacaine 7.5 mg/ml
was administered to achieve a T4 level of sensory block. The procedure was per-
formed under general anesthesia involving tracheal intubation and control venti-
lation. The induction was achieved by intravenous propofol 2 mg/kg
(Propofol-Lipuro 1%, B. Braun, Melsungen, Germany) and fentanyl 3e5 mg/kg
(Fentanyl, Janssen-Cilag, Athens, Greece). Neuromuscular blockade was achieved
with vecuronium bromide 0.1 mg/kg (Norcuron 1 mg/ml, N.V. Organon, Oss,
Netherlands). All patients were monitored intraoperatively with a triple lumen
central venous catheter, which was introduced in the right or left internal jugular
vein. Invasive arterial lines introduced in the right or the left radial arteries were also
utilized. A nasogastric tube, a urinary catheter, core temperature monitoring, forced
warm air blankets and the use of sequential calf compression devices were all
employed. Patients at the induction also received intravenous dexamethasone 8 mg
(Dexaton 4 mg/ml Vianex, Athens, Greece) ondansetron 4 mg (Vefron 8 mg/4 ml,
Opus-Materia, Paleo Faliro, Greece) and/or metoclopramide 10 mg (Primperan,
Sanoﬁ-Aventis, Athens, Greece) as prophylaxis against postoperative nausea and
vomiting (PONV).
At the end of the procedure, all patients were transferred, intubated, and
admitted to the ICU to tightly control their hemodynamic parameters (BP, CVP, HR)
for possible hemorrhagic diathesis, diuresis and temperature. The extubation was
performed upon arrival to the ICU along with the removal of the nasogastric tube.
The epidural catheter was maintained either 48 or 96 h after its insertion
(depending on the duration of the stay). Postoperatively, patients received a stan-
dard continuous infusion of ropivacaine 2mg/ml in a dose of 15e25mg/h, titrated to
effect (VAS score  3).13 At the same time, all the patients received intravenous
paracetamol (Apotel 1 g, Uni-Pharma, Athens, Greece) in a dose of 2 g in 4 divided
doses during the ﬁrst day, which was increased to 4 g in 4 divided doses from the
second day of their stay in the ICU.
Epidural catheterswere removed on postoperative day 5 in group A and on day 3
in group B. The practice was to remove the catheter if the INR was <1.6. If it was
prolonged, FFPs were given before removal of the epidural catheter.
3. Statistical analysis
Continuous data were described as medians (range) and
analyzed with Student’s t test. Categorical data were described as
numbers and percentages and analyzed with the x2 test. A p valueof less than 0.05 was considered statistically signiﬁcant. Statistical
analysis was performed using SPSS for Mac, version 20.0.0 (SPSS
Inc., Chicago, IL, USA).4. Results
The demographics and clinical details are reported in Table 1.
The mean duration of surgery in group A was 296 min (range 174e
510), and in group B, 290 min (range 156e410), p > 0.05. The mean
blood loss was 166.7 ml (range 0e500) in group A and 173.9 ml
(range 0e500) in group B, p > 0.05. Other details of the hepatic
resections are reported in Table 2. Hemihepatectomy was the most
common type of operation in both groups (7/24 in group A & 16/24
in group B), followed by extended hemihepatectomy (5/24 in group
A & 5/24 in group B). The types of hepatectomies are presented in
Table 3.
The oral ﬂuid intake for group A was 39.8 h (range 38e42), and
for group B, 41.9 h (range 38e57), p ¼ 0.129. Eleven patients (45%)
received opioids in group A, and 22 (91.6%), in group B. Discon-
tinuation of opioids was achieved after 2 days for group A and 3.95
days for group B, p ¼ 0.001. Laxatives were used in 17 patients
(70.8%) in group A and in 21 (87.5%) in group B. The time to func-
tional recovery was 5.5 days (range 4e7) in group A and 5.3 days
(range 4e8) in group B, p ¼ 0.467 (Table 4).
No perioperative mortality was recorded (90 days). Major
complications occurred in four patients in group A and in four
patients in group B (Table 5). The length of stay was 6.9 days (range
5e13) in group A and 6.1 days (range 5e12) in group B, p ¼ 0.152.
One patient was readmitted in group A, and two, in group B. The
total length of stay was 7.1 days (range 5e13) in group A and 6.4
days (range 5e12) in group B, p ¼ 0.250.5. Discussion
In this study, we investigated the impact of reducing the dura-
tion of the epidural catheter in major hepatic resections from 4 to 2
days. Although several studies have been published in the literature
regarding ERAS programs of liver resection, the optimal duration of
epidural analgesia has not been standardized.3,4,14e17
Not long ago, liver resection moved from a high-risk procedure
with signiﬁcant mortality (over 5%) and morbidity to a safe, routine
surgery.18e20 The adoption of hepatic parenchyma transection de-
vices with the advances in the perioperative anesthesiologic
management resulted in the reduction of bleeding and parenchyma
resection time.21 With the introduction of ERAS protocols, the
beneﬁts of advances in the technique and anesthesia are increasing.
Although in various studies, themethodology of the protocols is not
Table 4
Primary and secondary outcomes.
Groups A (n ¼ 24) B (n ¼ 24) p-Value
LoS (days) 6.9 (5e13) 6.1 (5e12) 0.152
Readmissions, (n) 1 2
Total LoS (days) 7.1 (5e13) 6.4 (5e12) 0.250
Oral ﬂuid intake (hours) 39.8 (38e42) 41.9 (38e57) 0.129
Functional recovery (days) 5.5 (4e7) 5.3 (4e8) 0.467
Opioid use (n) 11 (45.8%) 22 (91.6%)
Opioid duration (days) 2 (1e5) 3.95 (2e7) 0.001





Summary of operative and postoperative details.
Groups A (n ¼ 24) B (n ¼ 24) p-Value
Operation time (min) 296 (174e510) 290 (156e410) 0.809
Blood loss (mL) 166.7 (0e500) 173.9 (0e500) 0.861
Drain (n) 16 (75%) 21 (87.5%)
Drain removal (days) 4 (3e7) 4.2 (3e10) 0.097
Max CVP (cmH2O) 5.5 (4e8) 5.5 (4e8) 0.873
Max Glu (mg/dL) 132.6 (99e208) 132 (98e202) 0.952
Min Glu (mg/dL) 74.4 (55e96) 74.5(57e98) 0.982
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number of readmissions, are improved compared with the pre-
ceding era.4,16 The other two important points, morbidity and
mortality, although variable among the different studies (38e45%),
show no important differences with ERAS programmes.9,19 How-
ever, not all the referred complications have been graded according
to the Dindo-Clavien Classiﬁcation System, which makes it difﬁcult
to draw deﬁnitive conclusions.
ERAS studies dealing with open liver surgery are emerging very
fast in the literature. According to the review article of Coolsen
et al.,16 the most inﬂuential are three case control studies,7,22,23 two
randomized systematic trials (RCT)3,11 and one retrospective case
series.24 None of these studies dealt with the optimal duration of
postoperative analgesia using an epidural catheter. In the RCT study
of Koea et al., in which a comparison between epidural and intra-
thecal analgesia was performed, both types of analgesia remained
for 3 days.3 In another study performed by Connor et al., again
using both types of postoperative analgesia, the epidural catheter
remained for 6 days (range 5e10), while the intrathecal catheter
stayed for 3 (range 2e24).4
Stamenkovic et al. studied the optimal time of epidural catheter
removal but outside of the ERAS programs. The aim of this study
was to identify the “safe” time to remove the epidural catheter
using as criteria the coagulopathy perspective and not the LoS. In
the 123 patients who underwent liver resection, the catheter was
removed on day 5 (1e11) without any epidural or spinal
hematoma.17
In our study, patients who maintained the epidural catheter for
4 days had comparable functional recoveries with thosewho kept it
for only 2 days (p ¼ 0.467). LoS and total LoS, although not signif-
icantly different (p ¼ 0.152 & p ¼ 0.250) show a reduction in the
duration of hospitalization for group B. This is most likely due to a
type II error (false negative) because the number of patients in each
group was relatively small.
Both patient groups had similar operative and postoperative
data; therefore these parameters could not have any effect on the
outcomes of our FT program. However, since all hepatectomies in
the control group were performed earlier (year-wise) than hepa-
tectomies in the study group, potential selection bias in regards
with surgeons’ operative experience could not be eliminated.
An important observation is that the group of patients whowere
managed with 2 days of the epidural catheter had an increased




Hemihepatectomy plus  1 metastasectomies 2 0
Extended hemihepatectomy 5 5
Multiple segmentectomy (2 segments) 2 2
Central hepatectomy 3 1
Repeat hepatectomy 3 0patients who received opioids in group B was the double the
number in group A. Not only didmore patients need opioids but the
duration of their use also doubled. Laxatives, although not directly
correlated with the duration of hospitalization, as shown by Hen-
dry et al.,8 were used in almost all patients who had the epidural
catheter for only 2 days, most likely because these patients used
signiﬁcantly more opioids, but laxative use was not permitted to
compromise the primary end point, the hospital LoS.
Major complications included three bile leakages in each group
(all managed by CTguided drainage) and one case of hemorrhage in
each group (managed with blood transfusion alone). Bile leakage
was the cause of the three readmissions in each group. Nomortality
or any other major complication was recorded. In all the groups,
oral food intake was achieved early, with no signiﬁcant differences
among the groups.
In conclusion, the removal of the epidural catheter on post-
operative day 3may lead to a decrease in the LoS without an impact
on morbidity, mortality or readmission rates. However, its removal
certainly increased the need for opioid analgesia. In view of our
results, and although the number of patients in the two groups was
limited, a compromise should be reached between the two time
points of epidural catheter removal. Therefore, the optimal dura-
tion of the epidural catheter might be 3 days. Naturally, more
studies with a larger number of patients are warranted to conﬁrm
our suggestion.
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Urinary tract infection 5 3
Dindo-Clavien classiﬁcation
Grade I 7 5
Grade II 1 1
Grade III 3 3
Grade IV 0 0
Grade V 0 0
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